EdgarLookup

Main Street Capital CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Main Street Capital CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
8.7%
Return on Assets
Net income ÷ assets
0.9x
Debt-to-Equity
Total liabilities ÷ equity

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $493.40M Feb 27, 2026
FY2025 Dec 31, 2024 $508.08M Feb 27, 2026
FY2025 Dec 31, 2023 $428.45M Feb 27, 2026
FY2024 Dec 31, 2022 $241.61M Feb 28, 2025
FY2023 Dec 31, 2021 $330.76M Feb 23, 2024
FY2022 Dec 31, 2020 $29.38M Feb 24, 2023

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($45.71M) Feb 27, 2026
FY2025 Dec 31, 2024 ($87.12M) Feb 27, 2026
FY2025 Dec 31, 2023 $285.32M Feb 27, 2026
FY2024 Dec 31, 2022 ($246.94M) Feb 28, 2025
FY2023 Dec 31, 2021 ($515.37M) Feb 23, 2024
FY2022 Dec 31, 2020 ($54.08M) Feb 24, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.68B Feb 27, 2026
FY2025 Dec 31, 2024 $5.12B Feb 27, 2026
FY2024 Dec 31, 2023 $4.44B Feb 28, 2025
FY2023 Dec 31, 2022 $4.24B Feb 23, 2024
FY2022 Dec 31, 2021 $3.69B Feb 24, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.69B Feb 27, 2026
FY2025 Dec 31, 2024 $2.32B Feb 27, 2026
FY2024 Dec 31, 2023 $1.97B Feb 28, 2025
FY2023 Dec 31, 2022 $2.13B Feb 23, 2024
FY2022 Dec 31, 2021 $1.90B Feb 24, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.99B Feb 27, 2026
FY2025 Dec 31, 2024 $2.80B Feb 27, 2026
FY2025 Dec 31, 2023 $2.48B Feb 27, 2026
FY2025 Dec 31, 2022 $2.11B Feb 27, 2026
FY2025 Dec 31, 2021 $1.79B Feb 27, 2026
FY2025 Dec 31, 2020 $1.51B Feb 27, 2026
FY2025 Dec 31, 2019 $1.54B Feb 27, 2026
FY2025 Dec 31, 2018 $1.48B Feb 27, 2026
FY2025 Dec 31, 2017 $1.38B Feb 27, 2026
FY2025 Dec 31, 2016 $1.20B Feb 27, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $535.34M Feb 27, 2026
FY2025 Dec 31, 2024 $402.46M Feb 27, 2026
FY2025 Dec 31, 2023 $206.00M Feb 27, 2026
FY2024 Dec 31, 2022 $77.27M Feb 28, 2025
FY2022 Dec 31, 2021 $51.79M Feb 24, 2023

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $41.96M Feb 27, 2026
FY2025 Dec 31, 2024 $78.25M Feb 27, 2026
FY2024 Dec 31, 2023 $60.08M Feb 28, 2025
FY2023 Dec 31, 2022 $49.12M Feb 23, 2024
FY2022 Dec 31, 2021 $32.63M Feb 24, 2023

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.46B Feb 27, 2026
FY2025 Dec 31, 2024 $2.12B Feb 27, 2026
FY2024 Dec 31, 2023 $1.80B Feb 28, 2025
FY2023 Dec 31, 2022 $2.00B Feb 23, 2024
FY2022 Dec 31, 2021 $1.80B Feb 24, 2023

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 27, 2026
FY2025 Dec 31, 2024 3 Feb 27, 2026
FY2025 Dec 31, 2023 4 Feb 27, 2026
FY2024 Dec 31, 2022 3 Feb 28, 2025
FY2023 Dec 31, 2021 2 Feb 23, 2024
FY2022 Dec 31, 2020 2 Feb 24, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 27, 2026
FY2025 Dec 31, 2024 3 Feb 27, 2026
FY2025 Dec 31, 2023 4 Feb 27, 2026
FY2024 Dec 31, 2022 3 Feb 28, 2025
FY2023 Dec 31, 2021 2 Feb 23, 2024
FY2022 Dec 31, 2020 2 Feb 24, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 89.83M Feb 27, 2026
FY2025 Dec 31, 2024 88.40M Feb 27, 2026
FY2024 Dec 31, 2023 84.83M Feb 28, 2025
FY2023 Dec 31, 2022 84.83M Feb 23, 2024
FY2022 Dec 31, 2021 70.70M Feb 24, 2023

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $378.01M Feb 27, 2026
FY2025 Dec 31, 2024 $356.84M Feb 27, 2026
FY2025 Dec 31, 2023 $302.89M Feb 27, 2026
FY2023 Dec 31, 2022 $192.30M Feb 23, 2024
FY2022 Dec 31, 2021 $170.20M Feb 24, 2023